HAMP and chronic kidney disease: However, adjustment for inflammation, the main driver of hepcidin in CKD, and for a main indicator of iron stores like ferritin had minimal, if any, effect on the risk for the combined outcome by ERFE in both HD and CKD cohorts included in this study.